90.89
+0.32
+(0.35%)
At close: April 17 at 4:00:01 PM EDT
90.62
-0.27
(-0.30%)
After hours: April 17 at 7:35:31 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 10 | 10 | 10 | 10 |
Avg. Estimate | 0.75 | 0.95 | 3.65 | 4.07 |
Low Estimate | 0.74 | 0.89 | 3.6 | 4 |
High Estimate | 0.76 | 1.03 | 3.7 | 4.19 |
Year Ago EPS | 0.77 | 0.92 | 3.46 | 3.65 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 11 | 11 | 11 | 11 |
Avg. Estimate | 352.57M | 374.18M | 1.48B | 1.57B |
Low Estimate | 350M | 371.39M | 1.47B | 1.55B |
High Estimate | 354.91M | 377M | 1.49B | 1.59B |
Year Ago Sales | 323.51M | 338M | 1.36B | 1.48B |
Sales Growth (year/est) | 8.98% | 10.70% | 9.12% | 6.12% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | 0.72 | 0.87 | 0.8 | 0.83 |
EPS Actual | 0.77 | 0.92 | 0.86 | 0.93 |
Difference | 0.05 | 0.05 | 0.06 | 0.1 |
Surprise % | 7.69% | 5.26% | 7.77% | 12.20% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0.75 | 0.95 | 3.65 | 4.07 |
7 Days Ago | 0.75 | 0.95 | 3.65 | 4.07 |
30 Days Ago | 0.75 | 0.95 | 3.65 | 4.07 |
60 Days Ago | 0.84 | 0.98 | 3.73 | 4.2 |
90 Days Ago | 0.83 | 0.97 | 3.72 | 4.13 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | 1 | 1 | 2 |
Up Last 30 Days | -- | 1 | 1 | 3 |
Down Last 7 Days | 7 | 5 | 6 | 5 |
Down Last 30 Days | 6 | 4 | 7 | 3 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
MMSI | -2.69% | 3.45% | 5.45% | 11.52% |
S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
Maintains | Barrington Research: Outperform to Outperform | 4/11/2025 |
Reiterates | Needham: Buy to Buy | 4/9/2025 |
Initiated | JP Morgan: Overweight | 3/28/2025 |
Maintains | Barrington Research: Outperform to Outperform | 2/26/2025 |
Maintains | Canaccord Genuity: Buy to Buy | 2/26/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 2/26/2025 |
Related Tickers
ICUI ICU Medical, Inc.
138.67
-0.34%
LMAT LeMaitre Vascular, Inc.
86.28
+1.90%
ANGO AngioDynamics, Inc.
9.52
+0.63%
NVST Envista Holdings Corporation
15.18
+1.07%
ATR AptarGroup, Inc.
143.83
-0.81%
XRAY DENTSPLY SIRONA Inc.
12.83
+1.42%
COO The Cooper Companies, Inc.
79.51
+1.64%
TFX Teleflex Incorporated
129.48
+0.99%
CZMWY Carl Zeiss Meditec AG
64.62
+1.27%
PLSE Pulse Biosciences, Inc.
17.74
+5.03%